Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Christopher Rovaldi > Profile

Christopher Rovaldi

Affiliations

  • Chief Operating Officer at Keros Therapeutics Inc. (KROS), 2024-02-16
  • Svp, Program Mgmt And Ops at Acceleron Pharma Inc (XLRN), 2018-04-04
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Keros Therapeutics Inc.
 KROS $65.00 1,728 Officer 0 2022-04-06 Filing
Keros Therapeutics Inc.
 KROS $58.83 105 Officer 0 2022-04-01 Filing
Keros Therapeutics Inc.
 KROS $57.97 366 Officer 105 2022-04-01 Filing
Keros Therapeutics Inc.
 KROS $56.89 287 Officer 471 2022-04-01 Filing
Keros Therapeutics Inc.
 KROS $56.20 104 Officer 758 2022-04-01 Filing